FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3179127112> ?p ?o ?g. }

• W3179127112 abstract "Targeted therapy for cancer using small molecules has progressed exponentially, but agents that can affect cancer cells rather than non-tumorigenic cells are crucial to avoid pernicious side effects. AP endonuclease-1/Redox factor-1 (APE1/Ref-1 or Ref-1) is a multifunctional protein with DNA repair activity and redox signaling activity as major functions. The DNA repair function is indispensable for cell survival. Its role as a redox factor that stimulates the DNA binding activity of numerous transcription factors (TFs) such as HIF-1α, NFΚB, STAT3, and AP-1 tends to be dysregulated in cancer cells. Ref-1 is overexpressed in many cancers including, aggressive and invasive pancreatic ductal adenocarcinoma (PDAC), which is the 3rd leading cause of death in U.S. The dense stroma of PDAC primarily constituting cancer-associated fibroblasts (CAFs) makes it highly hypoxic, nutrient poor, and drug resistant. Current treatment regimens offer only modest improvement in survival. Targeting the PDAC stroma or ECM did not result in clinical benefit thus far presumably due to complex interactions between PDAC and its TME. Better treatments options that selectively target the tumor within its protective stroma are hence needed. Our group was able to generate a Ref-1 redox inhibitor, APX3330, that completed Phase I clinical trial (NCT03375086) with a good safety profile, verified target engagement and a recommended phase II dose. However, its potency in preclinical models is in the high µM range indicating the need for more potent second-generation inhibitors. Based on initial SAR studies, we selected 13 second-generation compounds from > 350 that were further characterized for positive properties including increased efficacy for cell killing, mouse and human S9 fraction metabolic stability, plasma half-life, and in silico ADMET properties. Target engagement studies involving blockade of TF activity via luciferase assay and EMSA as well as validation of direct interaction of these inhibitors with Ref-1 using thermal shift assay are ongoing. In two 3D co-culture models, second-generation Ref-1 redox analogs suppressed tumor survival significantly while sparing the CAFs. These findings were confirmed in vivo with xenografts co-implanted with tumor and CAF lines. Gene expression and mitochondria functional data revealed Ref-1's control of TCA cycle in tumor cells, but not in CAFs. To confirm and compare the effects of Ref-1 redox signaling inhibitors in cells, CRISPR editing was used to generate Ref-1 redox deficient cell lines (Ref-1C65A). As confirmation of significantly reduced Ref-1 redox activity, PDAC cells expressing Ref-1C65A did not induce hypoxia marker (CA9) under hypoxia, similar to when Ref-1 was knocked down or blocked via small molecule inhibitor. Ref-1 redox signaling and validation for selective killing of PDAC cells leaving the stomal cells undisturbed paves the way to improved PDAC treatment.Citation Format: Silpa Gampala, Nayela Chowdhury, Olivia Babb, Rachel A. Caston, Randall S. Wireman, Hye-ran Moon, George Sandusky, Emily Hulsey, Bumsoo Han, Millie M. Georgiadis, Sara K. Quinney, Andi R. Masters, James H. Wikel, Mark R. Kelley, Melissa L. Fishel. Deciphering mechanisms of Ref-1 signaling and its inhibition in aggressive tumor-stroma PDAC models [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 1452." @default.
• W3179127112 created "2021-07-19" @default.
• W3179127112 creator A5006252571 @default.
• W3179127112 creator A5010036123 @default.
• W3179127112 creator A5010740808 @default.
• W3179127112 creator A5020446872 @default.
• W3179127112 creator A5032698717 @default.
• W3179127112 creator A5035459578 @default.
• W3179127112 creator A5041580310 @default.
• W3179127112 creator A5042286706 @default.
• W3179127112 creator A5054517691 @default.
• W3179127112 creator A5055500811 @default.
• W3179127112 creator A5061385868 @default.
• W3179127112 creator A5062363713 @default.
• W3179127112 creator A5062667350 @default.
• W3179127112 creator A5078967600 @default.
• W3179127112 creator A5090346945 @default.
• W3179127112 date "2021-07-01" @default.
• W3179127112 modified "2023-10-14" @default.
• W3179127112 title "Abstract 1452: Deciphering mechanisms of Ref-1 signaling and its inhibition in aggressive tumor-stroma PDAC models" @default.
• W3179127112 doi "https://doi.org/10.1158/1538-7445.am2021-1452" @default.
• W3179127112 hasPublicationYear "2021" @default.
• W3179127112 type Work @default.
• W3179127112 sameAs 3179127112 @default.
• W3179127112 citedByCount "0" @default.
• W3179127112 crossrefType "proceedings-article" @default.
• W3179127112 hasAuthorship W3179127112A5006252571 @default.
• W3179127112 hasAuthorship W3179127112A5010036123 @default.
• W3179127112 hasAuthorship W3179127112A5010740808 @default.
• W3179127112 hasAuthorship W3179127112A5020446872 @default.
• W3179127112 hasAuthorship W3179127112A5032698717 @default.
• W3179127112 hasAuthorship W3179127112A5035459578 @default.
• W3179127112 hasAuthorship W3179127112A5041580310 @default.
• W3179127112 hasAuthorship W3179127112A5042286706 @default.
• W3179127112 hasAuthorship W3179127112A5054517691 @default.
• W3179127112 hasAuthorship W3179127112A5055500811 @default.
• W3179127112 hasAuthorship W3179127112A5061385868 @default.
• W3179127112 hasAuthorship W3179127112A5062363713 @default.
• W3179127112 hasAuthorship W3179127112A5062667350 @default.
• W3179127112 hasAuthorship W3179127112A5078967600 @default.
• W3179127112 hasAuthorship W3179127112A5090346945 @default.
• W3179127112 hasConcept C121608353 @default.
• W3179127112 hasConcept C126322002 @default.
• W3179127112 hasConcept C134935766 @default.
• W3179127112 hasConcept C143425029 @default.
• W3179127112 hasConcept C185592680 @default.
• W3179127112 hasConcept C203014093 @default.
• W3179127112 hasConcept C204232928 @default.
• W3179127112 hasConcept C502942594 @default.
• W3179127112 hasConcept C52124034 @default.
• W3179127112 hasConcept C552990157 @default.
• W3179127112 hasConcept C55493867 @default.
• W3179127112 hasConcept C71924100 @default.
• W3179127112 hasConcept C86803240 @default.
• W3179127112 hasConcept C96232424 @default.
• W3179127112 hasConceptScore W3179127112C121608353 @default.
• W3179127112 hasConceptScore W3179127112C126322002 @default.
• W3179127112 hasConceptScore W3179127112C134935766 @default.
• W3179127112 hasConceptScore W3179127112C143425029 @default.
• W3179127112 hasConceptScore W3179127112C185592680 @default.
• W3179127112 hasConceptScore W3179127112C203014093 @default.
• W3179127112 hasConceptScore W3179127112C204232928 @default.
• W3179127112 hasConceptScore W3179127112C502942594 @default.
• W3179127112 hasConceptScore W3179127112C52124034 @default.
• W3179127112 hasConceptScore W3179127112C552990157 @default.
• W3179127112 hasConceptScore W3179127112C55493867 @default.
• W3179127112 hasConceptScore W3179127112C71924100 @default.
• W3179127112 hasConceptScore W3179127112C86803240 @default.
• W3179127112 hasConceptScore W3179127112C96232424 @default.
• W3179127112 hasLocation W31791271121 @default.
• W3179127112 hasOpenAccess W3179127112 @default.
• W3179127112 hasPrimaryLocation W31791271121 @default.
• W3179127112 hasRelatedWork W2073769648 @default.
• W3179127112 hasRelatedWork W2138263320 @default.
• W3179127112 hasRelatedWork W2604970350 @default.
• W3179127112 hasRelatedWork W2605117944 @default.
• W3179127112 hasRelatedWork W2738453970 @default.
• W3179127112 hasRelatedWork W2774282247 @default.
• W3179127112 hasRelatedWork W2888600000 @default.
• W3179127112 hasRelatedWork W3203081572 @default.
• W3179127112 hasRelatedWork W4304891185 @default.
• W3179127112 hasRelatedWork W4319017166 @default.
• W3179127112 isParatext "false" @default.
• W3179127112 isRetracted "false" @default.
• W3179127112 magId "3179127112" @default.
• W3179127112 workType "article" @default.